Publications

20. MacAdams, M.R., White, R.H., Chipps, B.E., et al: Reduction of serum testosterone during chronic glucocorticoid therapy. Annals of internal medicine 104:648-651, 1986.

19. Chipps, B.E., Mak, H., Menkes, H.A., Mellits, E., Schuberth, K., Talamo, R., Talamo, J., Dermutt, S., Scherr, M.M.: Do weather conditions change pulmonary function in asthmatics
at summer camp. Journal of Asthma 21:15-20, 1984.

18. Chipps, B.E., Shinnar, S., Pickard, L., Garfinkel, D.J., Haller, J.A.: Spontaneous resolution of multilobar atelectasis secondary to fibrinous mediastinitis. Journal of Pediatrics, 100:935-937, 1982.

17. Mak, H., Chipps, B.E., Menkes, H.A., Schuberth, H.C., Talamo, R.C., Permutt, S.: Diurnal variation of air and helium - oxygen flow - volume curves in asthmatic children. British J. Disease of Chest 76:51-56, 1982.

16. Hyatt, A.C., Chipps, B.E., Kumor, K.M., Mellits, E.D., Lietman, P.S., Rosentein, B.J.: A double blind controlled trial of anti-pseudomonas chemotherapy of acute respiratory exacerbations in children with cystic fibrosis. J. Pediatrics 99 (2):307-311, 1981.

15. Boonyaprapa, S., Alderson, P.O., Garfinkel, D.J., Chipps, B.E., Wagner, N.E., Jr: Detection of pulmonary aspiration in infants and children with respiratory disease; concise communication. Journal of Nuclear Medicine Vol 21, #4, 1980.

14. Robotham, J.L., Menkes, H.A., Chipps, B.E., et al: A physiologic assessment of segmental bronchial atresia. American Review of Respiratory Disease 121:533-540, 1980.

***Updated 1/13/2021***

FROM CAPITAL ALLERGY & RESPIRATORY DISEASE CENTER

COVID Vaccine Update

Click Here to learn more

We do not expect to be a site for administration of the COVID19 vaccine.  Please check with your local public health department.

Use this link for more information on the state of California’s tiered system for vaccine administration.

https://covid19.ca.gov/vaccines/#When-can-I-get-vaccinated

************************************************

Due to current recommendations made by the US Government/CDC – The Following will go into effect until further notice.

Within the health care community as a whole, there has been an overall increase in the number of patients not seeking necessary medical treatment due to concerns about COVID-19.

If you have a medical problem, please contact your health care provider. It’s important not to delay seeking treatment when you need it.

We are currently open for in-office visits and will continue to offer telemedicine visits moving forward. We understand you might have concerns about coming in to see your health care provider. We want you to know about the steps we are taking to ensure your safety and help prevent the spread of infection:

o Mandatory Masking – All patients and visitors must be masked while in any of our care sites. Please wear a mask or face covering when you enter our facility.

o Limiting Individuals at Appointments – We will limit who is present at a patient visit. Only the patient will be allowed into the facility. If the patient is a minor, only one parent/guardian will be allowed to accompany the patient.

o Temperature Checks – All patients (and parent/guardian if patient is a minor) will have their temperatures checked at the door. Anyone with a temperature of 100 degrees or higher will be asked to reschedule their appointment or conduct the appointment via telemedicine.

o Employee Screening – We’ve instituted mandatory employee temperature screenings before each shift.

New Injection Hours – Effective 7/6/2020

Folsom Office
Monday 8:00-11:45 / 1-4:45
Tuesday Closed
Wednesday 8:00-11:45 / 1-4:45
Thursday 8:00-11:45 / 1-4:45
Friday 8:00-11:45 / 1-4:45

Roseville Office
Monday 9:00-11:45 / 1-4:45
Tuesday 8:00-11:45 / 1-4:45
Wednesday 8:00-11:45 / 1-4:45
Thursday 8:00-11:45 / 1-5:45
Friday 8:00-11:45 / 1-4:45

Sacramento
Monday 9:00-4:45
Tuesday 8:00-5:45
Wednesday 8:00-4:45
Thursday 9:00-4:45
Friday 8:00-4:45